Greenlight Biosciences

About:

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

Website: https://www.greenlightbiosciences.com

Twitter/X: GreenLightBio1

Top Investors: Khosla Ventures, Alexandria Venture Investments, S2G Ventures, Cormorant Asset Management, Morningside Venture Investments

Description:

GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver higher-quality RNA at a lower cost and more quickly than was ever before possible. GreenLight develops RNA products and collaborates with industry leaders to advance vaccine development, pandemic preparation, crop management, plant protection and support the health of bees and other pollinators.

Total Funding Amount:

$450M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Medford, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

contact(AT)greenlightbiosciences.com

Founders:

Andrey Zarur, James R. Swartz, Marta Ortega-Valle

Number of Employees:

101-250

Last Funding Date:

2022-08-12

IPO Status:

Delisted

© 2025 bioDAO.ai